A strategy for validation of bioanalytical methods
Authors:
- R.J. BarnabyRBR.J. Barnaby
- P. GrossiPGP. Grossi
- M. CugolaMCM. Cugola
- 1 February 1996
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 14 (4) , 375-388
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- An analysis of the Washington Conference Report on bioanalytical method validationJournal of Pharmaceutical and Biomedical Analysis, 1994
- Chiral assay methods for lifibrol and metabolites in plasma and the observation of unidirectional chiral inversion following administration of the enantiomers to dogsChirality, 1994
- Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(?)-hydroxychloroquine ratioChirality, 1993
- Chiral drugs: An industrial analytical perspectiveJournal of Pharmaceutical and Biomedical Analysis, 1991
- A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry — 1. Experimental considerationsJournal of Pharmaceutical and Biomedical Analysis, 1991
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry —2. Statistical analysesJournal of Pharmaceutical and Biomedical Analysis, 1991
- Method validation in the bioanalytical laboratoryJournal of Pharmaceutical and Biomedical Analysis, 1990
- Evaluation of criteria for the acceptance of bioanalytical dataJournal of Pharmaceutical and Biomedical Analysis, 1990
- Quantitation of adriamycin in plasma and urine: Comparative study of radioimmunoassay and high-performance liquid chromatography methodsJournal of Pharmaceutical and Biomedical Analysis, 1983